Cargando…
Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer
Lung cancer is the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) representing ∼85% of new diagnoses. The disease is often detected in an advanced metastatic stage, with poor prognosis and clinical outcome. In order to escape from the primary tumor, cancer...
Autores principales: | Cooke, Mariana, Baker, Martin J., Kazanietz, Marcelo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051914/ https://www.ncbi.nlm.nih.gov/pubmed/32158759 http://dx.doi.org/10.3389/fcell.2020.00118 |
Ejemplares similares
-
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
por: Maldonado, Maria del Mar, et al.
Publicado: (2020) -
Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation
por: Barrio-Real, Laura, et al.
Publicado: (2014) -
Rac‐GTPases and Rac‐GEFs in neutrophil adhesion, migration and recruitment
por: Pantarelli, Chiara, et al.
Publicado: (2018) -
GEFs: Dual regulation of Rac1 signaling
por: Marei, Hadir, et al.
Publicado: (2016) -
Non-Small Cell Lung Carcinoma Cell Motility, Rac Activation and Metastatic Dissemination Are Mediated by Protein Kinase C Epsilon
por: Caino, M. Cecilia, et al.
Publicado: (2012)